Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |